BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
235 hedge funds and large institutions have $3.19B invested in Blueprint Medicines in 2022 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 79 increasing their positions, 86 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4% less funds holding
Funds holding: 246 → 235 (-11)
13% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 39
15% less capital invested
Capital invested by funds: $3.74B → $3.19B (-$551M)
Holders
235
Holding in Top 10
5
Calls
$27.2M
Puts
$10.8M
Top Buyers
| 1 | +$164M | |
| 2 | +$72.5M | |
| 3 | +$35.3M | |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$34.6M |
| 5 |
State Street
Boston,
Massachusetts
|
+$22.7M |
Top Sellers
| 1 | -$71.2M | |
| 2 | -$26.4M | |
| 3 | -$20.2M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$18.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$18.5M |